| Literature DB >> 31924656 |
Léa Paolini1, Clément Adam1, Yves Delneste1,2, Pascale Jeannin3,2, Céline Beauvillain1,2, Laurence Preisser1, Simon Blanchard1,2, Pascale Pignon1, Valérie Seegers1,4, Louise-Marie Chevalier1,4, Mario Campone1,4, Romuald Wernert4, Véronique Verrielle4, Pedro Raro4, Norbert Ifrah1,5, Vincent Lavoué6,7, Philippe Descamps8, Alain Morel1,4, Véronique Catros9, Guillaume Tcherkez10, Guy Lenaers11, Cinzia Bocca11, Judith Kouassi Nzoughet11, Vincent Procaccio11,12.
Abstract
In established tumors, tumor-associated macrophages (TAM) orchestrate nonresolving cancer-related inflammation and produce mediators favoring tumor growth, metastasis, and angiogenesis. However, the factors conferring inflammatory and protumor properties on human macrophages remain largely unknown. Most solid tumors have high lactate content. We therefore analyzed the impact of lactate on human monocyte differentiation. We report that prolonged lactic acidosis induces the differentiation of monocytes into macrophages with a phenotype including protumor and inflammatory characteristics. These cells produce tumor growth factors, inflammatory cytokines, and chemokines as well as low amounts of IL10. These effects of lactate require its metabolism and are associated with hypoxia-inducible factor-1α stabilization. The expression of some lactate-induced genes is dependent on autocrine M-CSF consumption. Finally, TAMs with protumor and inflammatory characteristics (VEGFhigh CXCL8+ IL1β+) are found in solid ovarian tumors. These results show that tumor-derived lactate links the protumor features of TAMs with their inflammatory properties. Treatments that reduce tumor glycolysis or tumor-associated acidosis may help combat cancer. ©2020 American Association for Cancer Research.Entities:
Year: 2020 PMID: 31924656 DOI: 10.1158/2326-6066.CIR-18-0749
Source DB: PubMed Journal: Cancer Immunol Res ISSN: 2326-6066 Impact factor: 11.151